OvaScience Shareholder Attacks Director Compensation Deal
An investor in fertility treatment developer OvaScience Inc. has filed a derivative suit in Delaware federal court accusing the company's directors of breaching their fiduciary duties by awarding themselves excessive compensation...To view the full article, register now.
Already a subscriber? Click here to view full article